The recently approved medication, Mounjaro, is generating considerable buzz within the diabetes community as a potential advancement for controlling Adult-Onset Metabolic Disorder. Unlike some traditional approaches, Mounjaro utilizes a dual mechanism , targeting both GLP-1 receptors and the glucose-dependent receptor, leading to improved blood sug